共 147 条
[1]
Chobanian AV(2003)The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 2560-2571
[2]
Bakris GL(2013)Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences Eur Heart J 34 2940-2948
[3]
Black HR(2010)Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs Med Care 48 418-425
[4]
Cushman WC(2013)Determinants of patient adherence: a review of systematic reviews Front Pharmacol 4 91-1005
[5]
Green LA(2013)Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients Hypertens Res 36 1000-1203
[6]
Izzo JL(2005)Intentional and unintentional nonadherence to antihypertensive medication Ann Pharmacother 39 1198-489
[7]
Chowdhury R(1997)Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril J Hum Hypertens 11 483-3268
[8]
Khan H(1985)Long-term surveillance for adverse effects of antihypertensive drugs JAMA 253 3263-188
[9]
Heydon E(2008)Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials J Card Fail 14 181-509
[10]
Shroufi A(2004)An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors J Eval Clin Pract 10 499-334